Biotech Briefings

Stephen Weissman

Stephen Weissman

Partner, Washington, D.C.

[email protected]

+1 202.955.8678

Stephen Weissman, former Deputy Director for the Federal Trade Commission’s Bureau of Competition, is a Washington, D.C.-based partner and one of the cornerstones of the firm’s Antitrust and Competition Practice Group. A former top antitrust enforcer and accomplished defense lawyer, Steve brings exceptional experience and a practical approach to representing companies in antitrust investigations by the FTC and U.S. Department of Justice and high-stakes antitrust litigations. Chambers USA describes him as “a fantastic lawyer” and a “tour de force.” Who’s Who Legal – Competition (2022) identifies him as a “super star in the market who works on some of the most challenging” matters. In 2024, MergerLinks named Steve one of the “Top 10 Antitrust Lawyers in North America.

View Full Profile

Introducing Biotech Briefings

| Posted by Branden C. Berns; Aaron K. Briggs; Jane M. Love, Ph.D.; Mary Beth Maloney; Ryan A. Murr; Melanie E. Neary; John D.W. Partridge; Karen A. Spindler; Eric J. Stock; Todd J. Trattner; Stephen Weissman; Topic(s): Trends and Insights

Dear friends and colleagues,

We are excited to introduce Biotech Briefings, providing Gibson Dunn’s commentary and perspectives on the legal, business, and regulatory issues shaping the life sciences industry.

From groundbreaking developments in biopharma, medical devices, and diagnostics to the evolving landscape of IP, FDA and SEC regulation, Biotech Briefings delivers timely insights for companies, investors, and industry stakeholders.

Stay tuned for expert analysis on:

  • Key FDA, FTC & SEC developments
  • M&A, financing & strategic partnerships
  • Market dynamics shaping investment & innovation

We invite you to follow along for actionable insights at the crossroads of law, business, and science.

The Gibson Dunn Life Sciences Team